Literature DB >> 22065937

Effect of sarpogrelate on cardiovascular disorders.

Chihiro Shikata1, Masami Nemoto, Takanori Ebisawa, Akihiro Nishiyama, Nobuakira Takeda.   

Abstract

The present article, dedicated to Dr NS Dhalla on the occasion of the jubilee of his life's work, is a brief review of articles based on the authors' studies of sarpogrelate conducted in collaboration with Dr NS Dhalla. These studies on the effects of sarpogrelate on cardiovascular disorders have been ongoing for more than 10 years, and 10 articles have been published to date.

Entities:  

Keywords:  5-HT(2A) receptors; Cardiovascular disorders; Sarpogrelate; Serotonin

Year:  2011        PMID： 22065937      PMCID： PMC3209543     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN： 1205-6626


  10 in total

1.  Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate.

Authors:  S K Sharma; P Zahradka; D Chapman; H Kumamoto; N Takeda; N S Dhalla
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

2.  Attenuation of the serotonin-induced increase in intracellular calcium in rat aortic smooth muscle cells by sarpogrelate.

Authors:  Harjot K Saini; Sushil K Sharma; Peter Zahradka; Hideo Kumamoto; Nobuakira Takeda; Naranjan S Dhalla
Journal:  Can J Physiol Pharmacol       Date:  2003-11       Impact factor: 2.273

3.  Mechanism of sarpogrelate action in improving cardiac function in diabetes.

Authors:  Ramesh K Goyal; Vijayan Elimban; Yan-Jan Xu; Hideo Kumamoto; Nobuakira Takeda; Naranjan S Dhalla
Journal:  J Cardiovasc Pharmacol Ther       Date:  2010-12-23       Impact factor: 2.457

4.  Blockade of 5-HT(2A) receptors by sarpogrelate protects the heart against myocardial infarction in rats.

Authors:  David Brasil; Rana M Temsah; Kanwal Kumar; Hideo Kumamoto; Nobuakira Takeda; Naranjan S Dhalla
Journal:  J Cardiovasc Pharmacol Ther       Date:  2002-01       Impact factor: 2.457

5.  Sarpogrelate diminishes changes in energy stores and ultrastructure of the ischemic-reperfused rat heart.

Authors:  R M Temsah; H Kumamoto; N Takeda; N S Dhalla
Journal:  Can J Physiol Pharmacol       Date:  2001-09       Impact factor: 2.273

6.  Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency.

Authors:  S K Sharma; D F Del Rizzo; P Zahradka; S K Bhangu; J P Werner; H Kumamoto; N Takeda; N S Dhalla
Journal:  Ann Thorac Surg       Date:  2001-06       Impact factor: 4.330

Review 7.  Therapeutic potentials of sarpogrelate in cardiovascular disease.

Authors:  Harjot K Saini; Nobuakira Takeda; Ramesh K Goyal; Hideo Kumamoto; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Cardiovasc Drug Rev       Date:  2004

8.  Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.

Authors:  Santosh K Sanganalmath; Judit Barta; Nobuakira Takeda; Hideo Kumamoto; Naranjan S Dhalla
Journal:  Can J Physiol Pharmacol       Date:  2008-04       Impact factor: 2.273

9.  Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality.

Authors:  Judit Barta; Santosh K Sanganalmath; Hideo Kumamoto; Nobuakira Takeda; István Edes; Naranjan S Dhalla
Journal:  Cardiovasc Toxicol       Date:  2008-08-27       Impact factor: 3.231

10.  Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure.

Authors:  Santosh K Sanganalmath; Andrea P Babick; Judit Barta; Hideo Kumamoto; Nobuakiya Takeda; Naranjan S Dhalla
Journal:  J Cell Mol Med       Date:  2007-12-14       Impact factor: 5.310
  10 in total
  2 in total

1.  Functional constituents of a local serotonergic system, intrinsic to the human coronary artery smooth muscle cells.

Authors:  Kannan Baskar; Swastika Sur; Vithyalakshmi Selvaraj; Devendra K Agrawal
Journal:  Mol Biol Rep       Date:  2015-04-11       Impact factor: 2.316

2.  Sarpogrelate Based Triple Antiplatelet Therapy Improved Left Ventricular Systolic Function in Acute Myocardial Infarction: Retrospective Study.

Authors:  Jae Hyuk Choi; Jung Rae Cho; Sang Min Park; Kunal Bikram Shaha; Floyd Pierres; Tserendavaa Sumiya; Kwang Jin Chun; Min Kyung Kang; Seonghoon Choi; Namho Lee
Journal:  Yonsei Med J       Date:  2017-09       Impact factor: 2.759
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.